Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin- 2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent

Cheng Hua Jin, Maddeboina Krishnaiah, Domalapally Sreenu, Vura B. Subrahmanyam, Kota S. Rao, Hwa Jeong Lee, So Jung Park, Hyun Ju Park, Kiho Lee, Yhun Yhong Sheen, Dae Kee Kim

Research output: Contribution to journalArticlepeer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin- 2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds